Evidence map›Paper›PMID 29203926›Full record

ArticleNature communications2017

Pandemic H1N1 influenza A viruses suppress immunogenic RIPK3-driven dendritic cell death.

Boris M Hartmann, Randy A Albrecht, Elena Zaslavsky, German Nudelman, Hanna Pincas, Nada Marjanovic, Michael Schotsaert, Carles Martínez-Romero, Rafael Fenutria, Justin P Ingram and 5 more

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed
4.3field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed, 49 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Review
  16. Article
  17. M1 Macrophages Are More Susceptible to Necroptosis.Journal of cellular immunology · 2021
    Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 2 institutions in 1 country.

Boris M HartmannDepartment of Neurology, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA.ORCID http://orcid.org/0000-0002-5649-6776
Randy A AlbrechtDepartment of Microbiology and Global Health & Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA.ORCID http://orcid.org/0000-0003-4008-503X
Elena ZaslavskyDepartment of Neurology, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA.
German NudelmanDepartment of Neurology, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA.
Hanna PincasDepartment of Neurology, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA.
Nada MarjanovicDepartment of Neurology, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA.
Michael SchotsaertDepartment of Microbiology and Global Health & Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA.
Carles Martínez-RomeroDepartment of Microbiology and Global Health & Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA.ORCID http://orcid.org/0000-0001-8888-7715
Rafael FenutriaDepartment of Microbiology and Global Health & Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA.
Justin P IngramFox Chase Cancer Center, Philadelphia, PA, 19111, USA.
Irene RamosDepartment of Microbiology and Global Health & Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA.
Ana Fernandez-SesmaDepartment of Microbiology and Global Health & Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA.
Siddharth BalachandranFox Chase Cancer Center, Philadelphia, PA, 19111, USA.
Adolfo García-SastreDepartment of Microbiology and Global Health & Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA.
Stuart C SealfonDepartment of Neurology, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA. stuart.sealfon@mssm.edu.
Icahn School of Medicine at Mount Sinai · USFox Chase Cancer Center · US

Funding

Virus CoreU19AI106754 · NIAID · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI ALBRECHT, RANDY A. · 2013 to 2017
$26.0M
Project I: Immunity to Influenza in Primary Lung Epithelial CellsU19AI117873 · NIAID · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI HAYOT, FERNAND · 2015 to 2019
$8.6M
MODULATION OF INNATE AND ADAPTIVE IMMUNITY BY DENGUE VIRUSR01AI073450 · NIAID · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI FERNANDEZ-SESMA, ANA · 2008 to 2017
$3.3M
NIAID NIH HHS HHSN272201400008CNIAID NIH HHS R01 AI073450NIAID NIH HHS U19 AI106754NIAID NIH HHS U19 AI117873
6 · The paper itself

Abstract

The risk of emerging pandemic influenza A viruses (IAVs) that approach the devastating 1918 strain motivates finding strain-specific host-pathogen mechanisms. During infection, dendritic cells (DC) mature into antigen-presenting cells that activate T cells, linking innate to adaptive immunity. DC infection with seasonal IAVs, but not with the 1918 and 2009 pandemic strains, induces global RNA degradation. Here, we show that DC infection with seasonal IAV causes immunogenic RIPK3-mediated cell death. Pandemic IAV suppresses this immunogenic DC cell death. Only DC infected with seasonal IAV, but not with pandemic IAV, enhance maturation of uninfected DC and T cell proliferation. In vivo, circulating T cell levels are reduced after pandemic, but not seasonal, IAV infection. Using recombinant viruses, we identify the HA genomic segment as the mediator of cell death inhibition. These results show how pandemic influenza viruses subvert the immune response.

Indexed as

Adaptive ImmunityCD8-Positive T-LymphocytesCell DeathDendritic CellsHumansImmunity, InnateInfluenza A Virus, H1N1 SubtypeInfluenza, HumanIn Vitro TechniquesLymphocyte ActivationReceptor-Interacting Protein Serine-Threonine KinasesT-LymphocytesReceptor-Interacting Protein Serine-Threonine KinasesRIPK3 protein, human

Identifiers

PMID29203926
PMCPMC5715119
OpenAlexW2769821241

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.